CLEMENTIA PHARMACEUTICALS INC.

MONTREAL, A8 How do I update this listing?

Clementia Pharmaceuticals is based out of Montreal. Clementia Pharmaceuticals Inc. operates as a pharmaceutical company. The Company provides research and development of drugs, medicines, and other cure for people affected by rare and disabled diseases. Clementia Pharmaceuticals serves customers in Canada and the United States. The firm last filed a Form D notice of exempt offering of securities on 2015-07-07. The notice included securities offered of Equity

Create Alert

Contact Info

clementia pharmaceuticals inc.
4150 ST CATHERINE STREET WEST
MONTREAL A8    H3Z 2Y5

Business Phone: (514) 940-3600
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-07-07 D PHARMACEUTICALS Equity 59,999,141 59,999,141 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALLAN MANDELZYS subscription required
    DIRECTOR
CLARISSA DESJARDINS subscription required
    EXECUTIVE OFFICER DIRECTOR
DAVID P. BONITA subscription required
    DIRECTOR
DONNA ROY GROGAN subscription required
    EXECUTIVE OFFICER
ERIC GRINSTEAD subscription required
    EXECUTIVE OFFICER
FRANCOIS NADER subscription required
    DIRECTOR
JEAN-FRANCOIS PARISEAU subscription required
    EXECUTIVE OFFICER DIRECTOR
JEFFREY PACKMAN subscription required
    EXECUTIVE OFFICER
MICHAEL SINGER subscription required
    EXECUTIVE OFFICER
ROBERT HEFT subscription required
    DIRECTOR

Elevate your investments